APOE and Alzheimer disease: The mock-treated AD-fed ApoE−/− mice showed lower expression of the bone formation marker P1NP (p < 0.05, Figure 6B) and higher expression of the bone resorption marker CTX-1 (p < 0.01, Figure 6C) than CD-fed B6 and ApoE−/− mice.